Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Covid-19 pandemic: overcoming big pharma’s infectious disease market failure

Infectious diseases have been largely pushed to the wayside by big pharma because they are unable to bring the same profits as other conditions, such as cancer and chronic diseases. Octopus Ventures’ Uzma Choudry explains the reasons behind the failure and why she is hopeful the current Covid-19 pandemic will change attitudes towards the serious public health threats infectious diseases cause.

Close
Close
Close

Go Top